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Messenger mRNA has been prepared from post mortem human hypothalami and translated in a cell-free 
system. Using specific antibodies, biosynthetic precursors have been identified to neuropeptide Y (12 kDa), 
somatostatin (15 kDa) and vasopressin/neurophysin (19 kDa). 
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1. INTRODUCTION 
The assignment of neurotransmitter activity to a 
number of brain neuropeptides implies a signifi- 
cant involvement of these peptides in mental func- 
tion. To understand the regulation of such peptide 
hormones it is a prerequisite to gain a detailed 
breakdown of their biosynthetic pathways. How- 
ever, for obvious reasons there is little information 
on the initial stages of biosynthesis for human 
brain peptide precursors. Post mortem autolytic 
activity may rapidly degrade the early precursors 
and the mRNA encoding them. An exception has 
been the recent description of the cell-free syn- 
thesized precursor to human luteinizing hormone 
releasing hormone [l]. 
In part, this deficit can be circumvented by the 
isolation of genes from human genomic libraries 
(e.g., [2]); the precursor structures derived from 
these DNA sequences, however, remain hypotheti- 
cal until corroboratory data is obtained directly on 
the mRNA or protein precursor products of these 
genes. 
Here we report the isolation and cell-free 
translation of human post mortem hypothalamic 
Vasopressin Neurophysin Hormone precursor 
mRNA and the identification of the human 
prepro-hormones for neuropeptide Y, somatostat- 
in and vasopressin. 
2. EXPERIMENTAL 
2.1. Preparation of mRNA 
Human hypothalami were obtained at autopsy 
within 4 h (male, 44 years) or 12 h (male, 76 years) 
of death from cases where the cause of death was 
unrelated to brain function (both myocardial in- 
farctions). Hypothalami were immediately homo- 
genized in 6 vols of a solution containing 4 M 
guanidinium thiocyanate (Bethesda Research 
Laboratories, Neu Isenburg, FRG) and 1 M fl- 
mercaptoethanol. This homogenate is stable at 
room temperature in sealed containers for several 
days. 
Total RNA was isolated by centrifugation 
through CsCl [3] and enriched for poly(A)-con- 
taining sequences by oligo(dT)-cellulose chroma- 
tography [4]. A single human hypothalamus yields 
approx. 75 fig poly(A)-rich RNA. 
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2.2. Cell-free translation and immuno- 
precipitation of specific products 
Onepg poly(A)-rich RNA was translated in 5021 
reaction mixtures of rabbit reticulocyte lysate as 
described in [4], using as radiolabel, 100 &i 
[35S]methionine and 40 ,&i [35S]cysteine (both 
from New England Nuclear, translation grade) per 
reaction. Whereas cysteine is present in somato- 
statin, vasopressin and its associated neurophysin, 
methionine appears to be the only suitable label to 
identify human neuropeptide Y [5]. After 1 h in- 
cubation at 37”C, when trichloroacetic acid preci- 
pitation indicated a maximum specific incorpora- 
tion of -lo6 cpm/pg hypothalamic poly(A)-rich 
RNA, translation mixtures were supplemented by 
3 volumes of a buffer containing 10 mM Na-phos- 
phate (pH 7.6), 2% (v/v) Trasylol, 1 mM EDTA. 
Five mM cysteine, 5 mM methionine, 2 mM 
dithiothreitol, 1% (w/v) Nonidet P-40, 1% (w/v) 
sodium deoxycholate and 0.3% (w/v) SDS. To 
reduce nonspecific immunopre~ipitation, the 
above transIation solutions were preincubated for 
30 min at 4°C with 5Opg rabbit preimmune IgG 
and 100~1 of 10% (w/v) suspension of fixed and 
washed staphylococcal immunoadsorbent (IgSorb, 
the Enzyme Center, Boston, USA) and centrifuged. 
The supernatant fractions were then supplemented 
with 50 pg peptide-specific antibodies (see below) 
as IgG fractions obtained by 40% saturated ammo- 
nium sulfate precipitation. Where indicated, as 
competitive controls, the antibodies were quenched 
with an excess (lo-2Opg) of the respective unla- 
beled peptide antigen. After overnight incubation 
at 4°C the resultant immune complexes were 
isolated using staphylococcal immunoadsorbent, 
as described [4], and subjected to electrophoresis 
on 15% polyacrylamide-SDS gels followed by flu- 
orography. 
2.3. Antisera 
Anti-vasopressin, anti-somatostatin-14 (both 
from Ferring, Kiel, FRG), and anti-somatostat- 
in-28 (5309, by courtesy of Dr R. Benoit) have 
been characterized and described elsewhere [6,7]. 
Anti-neurophysin (by courtesy of Dr A. Weindl) 
appears to recognize predominantly the vasopres- 
sin-associated neurophysin among the products of 
rat and bovine hypothalamic translations (Ivell, 
unpublished). All these antisera have been demon- 
strated to be highly specific for their respective 
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antigenic sequences. Identification of precursors 
from other mammals using these antisera has been 
confirmed by tryptic peptide mapping or subse- 
quent sequence analysis [8,9]. Anti-neuropeptide Y 
was raised in rabbits using porcine neuropeptide Y 
(by courtesy of Dr K. Tatemoto) conjugated to 
bovine serum albumin using carbodiimide. Neuro- 
peptide Y antiseraurn no.1 1 was used here; this 
antiserum recognizes the intact neuropeptide Y 
molecule [lo]. 
3. RESULTS AND DISCUSSION 
In vitro translation is a reliable indicator of the 
quality of an mRNA preparation. The hypothala- 
mic specific incorporation of radioactive amino 
acids programmed by the human mRNA was no 
different from that observed with hypothalamic 
mRNA of rat or bovine origin where the delay 
from death to RNA preparation is only 1 min or 
20-40 min, respectively (unpublished). 
Electrophoresis of total translation products 
shows a number of high molecular mass proteins 
(fig.1, lane 2), implying minimal RNA degrada- 
tion. More critical than the delay between death 
and dissection is probably the speed with which 
RNase activity instigated by tissue damage or con- 
tamination can be eliminated by, for example, 
guanidinium thiocyanate homogenization. 
3.1. The human precursor to neuropeptide Y 
Previous studies have indicated that neuropep- 
tide Y-like immunoreactivity can be detected in 
substantial amounts in the human forebrain [l 11. 
The presence of large amounts of neuropeptide Y, 
somatostatin and vasopressin in human hypothala- 
mus suggested that this region would be appropri- 
ate for these studies. The demonstration that 
human neuropeptide Y contains a methionine re- 
sidue [S] indicated that this amino acid would be a 
suitable radiolabel for incorporation into a human 
NPY precursor. Recent work [ 121 using recom- 
binant DNA techniques has confirmed the methio- 
nine residue in NPY and demonstrated further me- 
thionine and cysteine in the signal sequence of the 
human precursor [ 121. 
Fig.1, lane 3, indicates that antisera raised 
against human neuropeptide Y are able to select a 
methionine and/or cysteine-labeled polypeptide of 
apparent molecular mass of 12 kDa which is not 
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Fig. 1. Immunoprecipitated precursors to neuropeptide Y, somatostatin and vasopressin/neurophysin among translation 
products programmed by human h~othalamic mRNA. Lanes 1, 2: 2~1 of total transIation mix before 
immunoprecipitation, in the absence (lane 1) and presence (lane 2) of human hypothalamic mRNA. Lanes 3-12: 
translates immunoprecipitated with anti-neuropeptide Y (a-NP-Y, lanes 3,4), anti-somatostatin-14 (a-SRIF-14, lanes 
5,6), anti-somatostatin-28 (a-SRIF-28, lanes 7,8), anti-vasopressin (a-AVP, lanes 9,lO) and anti-neurophysin (a-Np, 
lanes 11,12). Unlabeled antigen has been added where indicated as competitive control. Lanes 1,2,9-12 are after only 
4 days exposure to film, whereas lanes 3-8 are after 4 weeks exposure. Figures represent he apparent molecular masses 
(kDa) of the identified precursors. Calibration proteins: (a) bovine serum albumin, 69; (b) ovalbumin, 46; (c) carbonic 
anhydrase, 30; (d) lysozyme, 14.3. The human hypothaIamic mRNA used for the experiments illustrated was derived 
from the 44-year-old male. Similar results not shown were obtained for the other mRNA preparation. 
present on pretreating antisera with unlabeled an- 
tigen (lane 4). The other much weaker bands visi- 
ble in this figure and shared incommon between 
most lanes are a consequence of the Iong exposure 
time (4 weeks) required to visualize the evidently 
rare neuropeptide Y precursor. The apparent size 
of this prepro-neuropeptide Y is in good accord 
with the amino acid sequence which has been 
derived from the recently characterized human 
gene for neuropeptide Y [12]. This structure 
predicts a precursor of around 11 kDa 
(10.839 kDa) which is within the limit of resolution 
of the SDS gel system used here. 
3.2. The human precursor to somatostutin 
Although the human gene for somatostatin has 
been sequenced and located on chromosome 3 
[2,13], there is no direct information as to the 
mRNA or protein product of this gene in the 
human hypothalamus. Using antibodies which 
recognize either the C-terminus of somatostatin-14 
(fig. 1, lane 5; control, lane 6) or the N-terminus .of 
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somatostatin-28 (lane 7; control, lane 8), shows 
that both peptides are evidently present in a com- 
mon precursor of 15 kDa. This prepro-form is 
consistent with that predicted by the human gene 
sequence, where the somatostatin-28 molecule, 
and also the internal somatostatin-14 sequence, oc- 
cupy the C-terminus of the precursor. It is thus 
also comparable to the hypothalamic prepro- 
somatostatins recently described for other mam- 
malian species [4,9]. 
3.3. The human precursor to vasopressin 
The in vivo and in vitro synthesized precursors 
to nonapeptide vasopressin have been well 
characterized [14,15] and the sequences of both 
mRNA and gene have been laborated [8,16]. The 
hormone precursor includes vasopressin im- 
mediately following the signal peptide which cues 
the nascent polypeptide into the endoplasmic 
reticulum. The vasopressin sequence is followed by 
the vasopressin-associated neurophysin found 
together with the hormone in neurosecretory 
granules. The C-terminus of the precursor is oc- 
cupied by a glycopeptide whose function is not yet 
known. All these data relate to the rat or bovine 
hormone. In the human, a similar structure seems 
probable, since proteins of 20-30 kDa, believed to 
contain both vasopressin and neurophysin se- 
quences, have been observed in human pituitary 
extracts [ 171 and in lung carcinomas [181. Further- 
more, a C-terminal glycopeptide-like molecule has 
been identified in human hypothalamus and 
pituitary, and its histological distribution parallels 
exactly that of vasopressin and neurophysin [19]. 
Cell-free translation of mRNA from the human 
hypothalamus (fig. 1, lanes 9- 12) indicates heavy 
labeling of a precursor of 19 kDa which contains 
antigenic determinants to both arginine vasopres- 
sin (lane 9; control, lane 10) and neurophysin (lane 
11; control, lane 12). Since no endoplasmic reti- 
cular membranes are present, this polypeptide re- 
presents the unglycosylated prepro-hormone. This 
result agrees well not only with the evidence from 
other species but also with the limited human data 
[17,18] and implies a similar common precursor 
molecule to both vasopressin and its associated 
neurophysin. 
This report confirms the biosynthesis of three 
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peptide hormones, neuropeptide Y, somatostatin 
and vasopressin, in the human hypothalamus and 
describes the longer polypeptides which are their 
precursors. The availability of human hypothala- 
mic mRNA of good quality should allow the explo- 
ration of further brain biosynthetic pathways. 
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